
Franklin Resources’s Teva Pharmaceuticals TEVA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $255K | Buy |
+15,225
| New | +$255K | ﹤0.01% | 2615 |
|
2025
Q1 | – | Sell |
-46,826
| Closed | -$1.03M | – | 3055 |
|
2024
Q4 | $1.03M | Sell |
46,826
-108,265
| -70% | -$2.39M | ﹤0.01% | 1974 |
|
2024
Q3 | $2.67M | Buy |
155,091
+90,920
| +142% | +$1.57M | ﹤0.01% | 1629 |
|
2024
Q2 | $1.04M | Buy |
+64,171
| New | +$1.04M | ﹤0.01% | 1910 |
|
2021
Q4 | – | Sell |
-12,289
| Closed | -$120K | – | 2552 |
|
2021
Q3 | $120K | Sell |
12,289
-7,691
| -38% | -$75.1K | ﹤0.01% | 2306 |
|
2021
Q2 | $198K | Buy |
19,980
+5,487
| +38% | +$54.4K | ﹤0.01% | 1849 |
|
2021
Q1 | $167K | Sell |
14,493
-162,181
| -92% | -$1.87M | ﹤0.01% | 1827 |
|
2020
Q4 | $1.71M | Buy |
176,674
+162,806
| +1,174% | +$1.57M | ﹤0.01% | 1317 |
|
2020
Q3 | $125K | Buy |
+13,868
| New | +$125K | ﹤0.01% | 1704 |
|
2020
Q1 | – | Sell |
-19,916,016
| Closed | -$195M | – | 1562 |
|
2019
Q4 | $195M | Sell |
19,916,016
-21,560,376
| -52% | -$211M | 0.1% | 235 |
|
2019
Q3 | $285M | Sell |
41,476,392
-20,166,739
| -33% | -$139M | 0.16% | 171 |
|
2019
Q2 | $569M | Sell |
61,643,131
-2,980,753
| -5% | -$27.5M | 0.3% | 91 |
|
2019
Q1 | $1.01B | Sell |
64,623,884
-1,483,372
| -2% | -$23.3M | 0.54% | 39 |
|
2018
Q4 | $1.02B | Sell |
66,107,256
-426,849
| -0.6% | -$6.58M | 0.62% | 32 |
|
2018
Q3 | $1.43B | Sell |
66,534,105
-5,690,773
| -8% | -$123M | 0.71% | 21 |
|
2018
Q2 | $1.76B | Sell |
72,224,878
-907,895
| -1% | -$22.1M | 0.9% | 12 |
|
2018
Q1 | $1.25B | Sell |
73,132,773
-6,355,366
| -8% | -$109M | 0.63% | 25 |
|
2017
Q4 | $1.51B | Buy |
79,488,139
+6,009,897
| +8% | +$114M | 0.72% | 17 |
|
2017
Q3 | $1.29B | Buy |
73,478,242
+6,681,345
| +10% | +$118M | 0.63% | 29 |
|
2017
Q2 | $2.22B | Buy |
66,796,897
+6,685,844
| +11% | +$222M | 1.11% | 8 |
|
2017
Q1 | $1.93B | Buy |
60,111,053
+3,475,750
| +6% | +$112M | 0.98% | 8 |
|
2016
Q4 | $2.05B | Buy |
56,635,303
+9,775,505
| +21% | +$354M | 1.06% | 8 |
|
2016
Q3 | $2.16B | Buy |
46,859,798
+5,648,249
| +14% | +$260M | 1.13% | 7 |
|
2016
Q2 | $2.07B | Buy |
41,211,549
+4,389,590
| +12% | +$220M | 1.11% | 8 |
|
2016
Q1 | $1.97B | Sell |
36,821,959
-4,140,536
| -10% | -$222M | 1.05% | 9 |
|
2015
Q4 | $2.69B | Sell |
40,962,495
-6,954,803
| -15% | -$457M | 1.36% | 3 |
|
2015
Q3 | $2.71B | Sell |
47,917,298
-2,204,102
| -4% | -$124M | 1.34% | 3 |
|
2015
Q2 | $2.96B | Sell |
50,121,400
-4,925,570
| -9% | -$291M | 1.34% | 3 |
|
2015
Q1 | $3.43B | Buy |
55,046,970
+219,468
| +0.4% | +$13.7M | 1.55% | 2 |
|
2014
Q4 | $3.15B | Sell |
54,827,502
-227,254
| -0.4% | -$13.1M | 1.43% | 4 |
|
2014
Q3 | $2.96B | Buy |
55,054,756
+72,794
| +0.1% | +$3.91M | 1.35% | 3 |
|
2014
Q2 | $2.88B | Buy |
54,981,962
+5,708,606
| +12% | +$299M | 1.27% | 4 |
|
2014
Q1 | $2.6B | Buy |
49,273,356
+6,179,870
| +14% | +$327M | 1.23% | 5 |
|
2013
Q4 | $1.73B | Buy |
43,093,486
+21,877,679
| +103% | +$877M | 0.84% | 16 |
|
2013
Q3 | $802M | Buy |
21,215,807
+3,057,576
| +17% | +$116M | 0.43% | 54 |
|
2013
Q2 | $712M | Buy |
+18,158,231
| New | +$712M | 0.41% | 58 |
|